Apparently, in the USA – and soon in all other countries – they will introduce new sanctions and rules for the creation, packaging and sale of medicines, since today the very eloquent results of one study of pharmaceutical specialists from the Massachusetts Technical University were presented. The study addresses the question of whether the so-called “inactive ingredients” in drugs are actually safe for most patients – their results have shown that in the modern pharmaceutical world everything can be much more complicated and diverse than that presented on the package of the drug.
In particular, the study concerned the consideration of some individual static and inactive ingredients – in particular gluten and fructose, which are usually used to increase the life cycle of a drug and improve its chemical stability. The study was conducted for many categories of patients using various drugs, and its results have shown that for some patients with a predisposition, sensitivity or allergic reaction to certain inactive components, these same components can be dangerous.
Heap of medical pills in white, blue and other colors. Pills in plastic package. Concept of healthcare and medicine.
And the main problem is that they are not always indicated on the labeling of drugs in pharmacies where they are dispensed to customers. Thus, the study very clearly demonstrates that even the safest, at first glance, inactive components can be really dangerous and harmful, albeit for a certain layer of patients with pronounced predispositions or allergies.
It is worth noting that at this stage in the United States this issue was often considered at the highest political level, and most likely very soon the rules for creating, labeling and dispensing drugs in this country will change – which means that similar changes can affect the European drug market. Be that as it may, this study provides a lot of food for thought.